ROS-Sensitive Nanoparticles Co-delivering Dexamethasone and CDMP-1 for the Treatment of Osteoarthritis Through Chondrogenic Differentiation Induction and Inflammation Inhibition

Objective: Osteoarthritis (OA) is a common subtype of arthritis. To date, treatment of OA focuses primarily on alleviating pain and improving joint function. The lack of a vascular system within synovial joints and the rapid removal of agents due to synovial exchange hinder continuous delivery of OA...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xiaodong, Li, Pengpeng, Cheng, Jian, Xu, Qiang, Lu, Beiji, Han, Conghui, Huo, Weiling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876336/
https://www.ncbi.nlm.nih.gov/pubmed/33585431
http://dx.doi.org/10.3389/fbioe.2021.608150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876336/
https://www.ncbi.nlm.nih.gov/pubmed/33585431
http://dx.doi.org/10.3389/fbioe.2021.608150

Ejemplares similares